Product Supply
This section is intended to provide information to healthcare professionals on any supply issues we are currently experiencing or any discontinuations. Please be reassured that MSD takes supply of its products very seriously and will be doing everything it can to mitigate any supply issues.
From time to time we may experience shortages of some products and may divest or discontinue others.
MSD UK customer services
(9am-5pm, Mon-Fri)
0208 1548001
(Out of normal working hours, during public holidays and weekends, please contact our UK switchboard on 0208 1548000).
PHARMACEUTICAL SUPPLY STATUS
| Product Description | Supply Status | Estimated Resupply Date |
| None to report |
VACCINES SUPPLY STATUS
| Product Description | Supply Status | Estimated Resupply Date |
| GARDASIL® (National Immunisation Programme) | N/A | Please refer to ImmForm for NIP supply status |
| GARDASIL® | Discontinued | |
| GARDASIL® 9 | Full Supply | |
| VAQTA® Paediatric | Full Supply | |
| VAQTA® Adult | Full Supply | |
| HBVAXPRO® 5mcg | Full Supply | |
| HBVAXPRO® 10mcg | Full Supply | |
| HBVAXPRO® 40mcg | Full Supply | |
| M-M-RVAXPRO® (National Immunisation Programme) | N/A | Please refer to ImmForm for NIP supply status |
| M-M-RVAXPRO® | Full Supply | |
| PNEUMOVAX® 23 (pre-filled syringes) National Immunisation Programme | N/A | Please refer to ImmForm for NIP supply status |
| PNEUMOVAX® 23 (pre-filled syringes) | Full Supply | |
| VAXNEUVANCE▼ ((pneumococcal polysaccharide conjugate vaccine (15-valent, adsorbed))) | Full Supply | |
| VARIVAX® | Full Supply | |
| ZOSTAVAX® (National Immunisation Programme) | N/A | Please refer to ImmForm for NIP supply status |
| ZOSTAVAX® | Discontinued |
NOTIFICATIONS
MSD appoint Alloga and Alliance Healthcare as its exclusive distribution partners
From 1st February 2022, Alloga will exclusively manage the warehousing and logistics (pre wholesaler) and Alliance Healthcare Limited will be the wholesaler for MSD products across the UK, ensuring MSD vaccines and medicines get to those who need them.
The new distribution partnership with Alliance Healthcare is the result of a competitive and thorough tender process which was conducted to enable MSD to continually meets the needs of patients and those who care for them by ensuring timely distribution of products to hospitals, pharmacies, GP surgeries and clinics. The new partnership includes a strong network of dispensing points across the UK – all of which will optimise support for patients and ensure that those who need MSD’s vaccines and products can receive them.
Information about OncoTICE® (2-8 X 108 CFU Tice® BCG) powder for suspension
Due to increased global demand and as the primary supplier of OncoTICE®/(TICE® /BCG) in the UK, MSD has been experiencing supply constraints. To minimise disruption to patient care, available supply of OncoTICE®/(TICE® /BCG) is proportionally allocated across countries.
MSD are working with the Department of Health and Social Care (DHSC) and relevant professional organisations to ensure equitable distribution of the medicine across NHS.
British Association of Urological Surgeons (BAUS) guidance may be found here.
DISCONTINUATIONS
Product Description
Rebetol 200 mg hard capsules
This page is intended for use by UK healthcare professionals only. Trademarks appearing on this website are owned, licensed to, promoted or distributed by Merck & Co., Inc., Rahway, NJ, USA, its subsidiaries or affiliates, except as noted.
Job code: GB-NON-07416 | Date of preparation: May 2023